Affinity Asset Advisors, LLC Xenon Pharmaceuticals Inc. Transaction History

Affinity Asset Advisors, LLC

$596 Million
Q2 2025

A detailed history of Affinity Asset Advisors, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,100,000 shares of XENE stock, worth $46.4 Million. This represents 5.78% of its overall portfolio holdings.

Number of Shares

1,100,000

Previous 1,328,175 17.18%

Holding current value

$46.4 Million

Previous $44.6 Million 22.73%

% of portfolio

5.78%

Previous 4.97%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$28.23 - $38.37 $6.44 Million - $8.76 Million	-228,175 Reduced 17.18%	1,100,000 $34.4 Million
Q1 2025 May 14, 2025	BUY	$33.55 - $40.74 $5.6 Million - $6.8 Million	166,938 Added 14.38%	1,328,175 $44.6 Million
Q4 2024 Feb 13, 2025	BUY	$38.14 - $45.74 $656,618 - $787,459	17,216 Added 1.5%	1,161,237 $45.5 Million
Q3 2024 Nov 13, 2024	BUY	$36.12 - $43.96 $5.41 Million - $6.58 Million	149,794 Added 15.07%	1,144,021 $45 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $5.69 Million - $6.86 Million	156,840 Added 18.73%	994,227 $38.8 Million
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $16.1 Million - $18.9 Million	377,387 Added 82.04%	837,387 $36 Million
Q4 2023 Feb 13, 2024	BUY	$28.7 - $46.46 $4.58 Million - $7.41 Million	159,562 Added 53.11%	460,000 $21.2 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $8.2 Million - $9.54 Million	240,062 Added 397.61%	300,438 $10.3 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $1.03 Million - $1.29 Million	-29,624 Reduced 32.92%	60,376 $2.32 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $1.34 Million - $1.61 Million	40,000 Added 80.0%	90,000 $3.22 Million
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $1.65 Million - $1.97 Million	50,000 New	50,000 $1.97 Million
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $2.04 Million - $2.81 Million	-80,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $1.77 Million - $2.34 Million	-70,500 Reduced 46.84%	80,000 $2.45 Million
Q4 2021 Feb 11, 2022	BUY	$15.6 - $35.4 $1.57 Million - $3.56 Million	100,500 Added 201.0%	150,500 $4.7 Million
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $743,000 - $972,500	50,000 New	50,000 $764,000

Others Institutions Holding XENE

# of Institutions

221

Shares Held

72.7M

Call Options Held

336K

Put Options Held

309K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.63B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Account

Affinity Asset Advisors, LLC Xenon Pharmaceuticals Inc. Transaction History